Ben Powney

Ben Powney is currently a Team leader within the Neurology Innovation Centre at Eisai, UK. He has more than 15 years’ experience as an in vitro pharmacologist within the pharmaceutical industry including positions at Pfizer, Glaxosmithkline and Eisai. During this time he has led preclinical drug discovery projects from inception through to lead optimisation and currently leads a project as part of collaboration between Eisai and University College London. Ben’s current interests include the use of high content imaging and patient derived cell systems to study the roles of dysfunctional subcellular protein trafficking in neurodegeneration